BioVie Inc. (BIVI) Cash Flow Statement
Where BIVI’s cash came from and went, FY2026
June 30, 2026 · U.S. dollars- Cash from operations
- −$19.02B
- Capital expenditures
- $0
- Free cash flow
- −$19.02B
- Returned to shareholders
- —
- Change in cash
- −$8.57B cash at year-end $8.98B
Cash from operations
−$19.02B
Other financing
+$10.45B
Change in cash
−$8.57B
Drawn to scale: where the cash came from and how it was used. Hover for values.
BIVI operating cash flow, capex and free cash flow
Operating cash flowCapital expendituresFree cash flowFCF margin (right axis)
BIVI cash flow trends, FY2017–FY2026
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Operating cash flow | −$623,615FY2017 | −$19.02BFY2026 | — | |
| Capital expenditures | $0FY2017 | $0FY2026 | — | |
| Free cash flow | −$623,615FY2017 | −$19.02BFY2026 | — | |
| Stock-based compensation | $92,052FY2017 | $2.87BFY2026 | +215.8%/yr | |
| Dividends paid | $0FY2017 | $369.46BFY2025 | — | |
| Share buybacks (net) | $0FY2017 | $0FY2022 | — |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
BIVI cash flow by activity
OperatingInvestingFinancingChange in cash
BIVI net income vs operating cash flow
Net incomeOperating cash flow
Operating cash flow above net income usually means earnings are backed by cash (depreciation and stock-based pay are non-cash expenses).
BIVI cash flow statement
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating activities | ||||||||||
| Net income | −$22.07B | −$17.5M | −$32.1M | −$50.3M | −$26.1M | −$130.2M | −$16.7M | −$2.4M | −$2.4M | −$1.3M |
| Depreciation & amortization | $178,341 | $229,377 | $229,377 | $229,377 | $229,377 | $229,377 | $229,377 | $229,377 | $229,377 | $229,377 |
| Stock-based compensation | $2.87B | $2.5M | $4.7M | $6.4M | $6.2M | $3.0M | $24,846 | $64,860 | $893,484 | $92,052 |
| Change in working capital | −$80.9M | −$4.4M | −$86,843 | −$270,439 | $2.8M | $19,466 | $774,091 | −$451,927 | $642,401 | $385,628 |
| Other non-cash items | $255.2M | $212,092 | −$627,139 | $3.7M | −$2.1M | $116.5M | $14.0M | $100,400 | $26,519 | $0 |
| Cash from operating activities | −$19.02B | −$19.0M | −$27.9M | −$40.3M | −$19.0M | −$10.5M | −$1.6M | −$2.5M | −$621,341 | −$623,615 |
| Investing activities | ||||||||||
| Capital expenditures | $0 | −$5 | −$4 | $0 | $0 | −$3 | $0 | $0 | $0 | $0 |
| Investments (net) | — | $0 | $14.5M | −$14.3M | −$14.3M | −$14.3M | −$14.3M | $0 | $0 | $0 |
| Acquisitions & other investing | — | — | $4 | $0 | $0 | $3 | $0 | $0 | $0 | $0 |
| Cash from investing activities | — | — | $14.5M | −$14.3M | −$14.3M | −$14.3M | −$14.3M | $0 | $0 | $0 |
| Financing activities | ||||||||||
| Dividends paid | — | −$369.46B | −$886,423 | — | — | −$53.6M | −$17.1M | −$48,659 | $0 | $0 |
| Share repurchases & issuance (net) | — | — | — | — | $18.5M | — | — | −$1.1M | $0 | $0 |
| Net borrowing (repayment) | $0 | −$5.8M | $0 | $0 | $14.6M | −$1.4M | $1.3M | −$244,300 | −$35,000 | $25,000 |
| Shares issued | $10.5M | $15.7M | $27.8M | $55.4M | $18.5M | $15.6M | $15.6M | $3.0M | $0 | $0 |
| Other financing | $10.45B | $369.47B | −$9.1M | $2,240 | −$18.5M | $54.3M | $1.5M | $1.2M | $697,000 | $480,000 |
| Cash from financing activities | $10.46B | $12.7M | $17.8M | $55.4M | $33.1M | $14.9M | $1.3M | $2.8M | $662,000 | $505,000 |
| Summary | ||||||||||
| Net change in cash | −$8.57B | −$6.3M | $4.4M | $819,167 | $14.1M | $4.5M | −$302,728 | $294,123 | $40,660 | −$118,616 |
| Cash at end of period | $8.98B | $17.5M | $23.8M | $19.5M | $18.6M | $4.5M | $37,195 | $339,923 | $45,800 | $5,141 |
| Free cash flow | −$19.02B | −$19.0M | −$27.9M | −$40.3M | −$19.0M | −$10.5M | −$1.6M | −$2.5M | −$621,341 | −$623,615 |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating activities | ||||||||||||
| Net income | −$5.6M | −$5.3M | −$6.1M | −$5.1M | −$3.5M | −$2.8M | −$7.1M | −$4.2M | −$4.9M | −$8.1M | −$8.4M | −$10.7M |
| Depreciation & amortization | $6,308 | $57,345 | $57,344 | $57,344 | $57,344 | $57,345 | $57,344 | $57,344 | $57,344 | $57,345 | $57,344 | $57,344 |
| Stock-based compensation | $589.71B | $1.6M | $486,728 | $538,947 | $683,181 | −$192,304 | $651,000 | $453,839 | $1.4M | $1.1M | $922,874 | $1.2M |
| Change in working capital | $1.2M | −$3.9M | −$2.1M | $1.4M | −$2.6M | $2.3M | −$162,523 | −$71,071 | −$28,146 | $934,709 | $2.1M | −$2.3M |
| Other non-cash items | −$589.71B | $19,585 | $3.2M | $18,253 | −$257,895 | −$634,191 | −$2.0M | $132,464 | −$523,823 | $104,691 | −$585,349 | −$445,500 |
| Cash from operating activities | −$4.1M | −$7.4M | −$4.4M | −$3.0M | −$5.6M | −$1.3M | −$8.6M | −$3.6M | −$4.0M | −$5.9M | −$5.9M | −$12.2M |
| Investing activities | ||||||||||||
| Capital expenditures | −$4 | $0 | $0 | $0 | $0 | $0 | $0 | −$4 | −$1 | −$4 | $0 | $0 |
| Investments (net) | — | — | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $14.5M |
| Acquisitions & other investing | — | — | — | — | — | — | — | — | — | — | — | $0 |
| Cash from investing activities | — | — | — | — | — | — | — | — | — | — | — | $14.5M |
| Financing activities | ||||||||||||
| Dividends paid | −$43.54B | −$43,544 | −$43,544 | −$43,544 | −$369.46B | −$369,465 | −$369,465 | −$325,041 | — | — | — | — |
| Share repurchases & issuance (net) | — | — | — | — | — | −$2.9M | — | — | — | — | — | — |
| Net borrowing (repayment) | $0 | $0 | $0 | $0 | $0 | $0 | −$3.4M | −$2.5M | — | — | — | — |
| Shares issued | $0 | $0 | $0 | $10.5M | $0 | $0 | $13.4M | $2.3M | $0 | $18.5M | $7.4M | $1.9M |
| Other financing | $10.50T | $43,544 | $43,544 | $43,544 | $13.10T | $3.3M | $3.3M | $325,041 | −$2.5M | −$2.5M | −$2.5M | −$2.5M |
| Cash from financing activities | $10.46T | $0 | $0 | $10.5M | $12.73T | $0 | $13.0M | −$240,937 | −$2.5M | $16.0M | $4.9M | −$594,164 |
| Summary | ||||||||||||
| Net change in cash | −$4.1M | −$7.4M | −$4.4M | $7.4M | −$5.6M | −$1.3M | $4.4M | −$3.8M | −$6.5M | $10.1M | −$987,972 | $1.8M |
| Cash at end of period | $9.0M | $13.1M | $20.5M | $25.0M | $17.5M | $23.2M | $24.4M | $20.0M | $23.8M | $30.4M | $20.2M | $21.2M |
| Free cash flow | −$4.1M | −$7.4M | −$4.4M | −$3.0M | −$5.6M | −$1.3M | −$8.6M | −$3.6M | −$4.0M | −$5.9M | −$5.9M | −$12.2M |
Negative numbers are cash paid out. Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported; data from EODHD.
BIVI cash generation
In fiscal 2026 (ended June 30, 2026), BioVie generated -$19.0 billion of cash from operations and spent $0 on capital expenditures, leaving free cash flow of -$19.0 billion. Cash and equivalents fell by $8.6 billion over the year.
Related: BIVI income statement, BIVI balance sheet. See the BIVI stock overview for the latest quote and news.
BIVI cash flow FAQ
What is BioVie's free cash flow?
BioVie's free cash flow was -$19.0 billion in fiscal 2026: -$19.0 billion of operating cash flow minus $0 of capital expenditures It was -$19.0 million a year earlier..
How much cash does BioVie generate from operations?
BioVie generated -$19.0 billion of cash from operating activities in fiscal 2026.